Dr. Howard Colman, MD, PhD
Claim this profileHuntsman Cancer Institute/University of Utah
Studies Glioblastoma
Studies Brain Tumor
12 reported clinical trials
31 drugs studied
Area of expertise
1Glioblastoma
Stage IV
Stage II
Stage I
2Brain Tumor
Stage IV
IDH positive
Stage III
Affiliated Hospitals
Clinical Trials Howard Colman, MD, PhD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
Eflornithine + Temozolomide
for Glioblastoma
The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma is newly diagnosed, and to evaluate safety and tolerability of this combination at that dose.
Recruiting1 award Phase 1
More about Howard Colman, MD, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Howard Colman, MD, PhD has experience with
- Temozolomide
- Abemaciclib
- Lomustine
- Surgery
- Magrolimab
- Vemurafenib
Breakdown of trials Howard Colman, MD, PhD has run
Glioblastoma
Brain Tumor
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Howard Colman, MD, PhD specialize in?
Howard Colman, MD, PhD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are Stage II.
Is Howard Colman, MD, PhD currently recruiting for clinical trials?
Yes, Howard Colman, MD, PhD is currently recruiting for 6 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Howard Colman, MD, PhD has studied deeply?
Yes, Howard Colman, MD, PhD has studied treatments such as Temozolomide, Abemaciclib, Lomustine.
What is the best way to schedule an appointment with Howard Colman, MD, PhD?
Apply for one of the trials that Howard Colman, MD, PhD is conducting.
What is the office address of Howard Colman, MD, PhD?
The office of Howard Colman, MD, PhD is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.